![Andrew Reardon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Reardon
Direttore/Membro del Consiglio presso
VERNALIS
Patrimonio netto: 10 M $ in data 31/05/2026
Profilo
Andrew Thomas Reardon is currently Director at Ligand UK Ltd. since 2022 and Secretary & Chief Legal Officer at Ligand Pharmaceuticals, Inc. since 2022.
Former positions include Senior Associate at Willkie Farr & Gallagher LLP, Principal at The United States Army (District of Columbia), and Vice President-Legal at Healthcare Royalty Management LLC.
Education includes graduate studies at The University of Iowa College of Law and undergraduate studies at State University of New York at Old Westbury.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/06/2026 | 41.382 ( 0,21% ) | 10 M $ | 31/05/2026 |
Posizioni attive di Andrew Reardon
| Società | Posizione | Inizio |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Consigliere Generale | 01/01/2022 |
| VERNALIS | Direttore/Membro del Consiglio | 01/11/2022 |
Precedenti posizioni note di Andrew Reardon
| Società | Posizione | Fine |
|---|---|---|
Willkie Farr & Gallagher LLP
 Willkie Farr & Gallagher LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
The United States Army (District of Columbia)
 The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Corporate Officer/Principal | - |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Corporate Officer/Principal | - |
Formazione di Andrew Reardon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Willkie Farr & Gallagher LLP
Willkie Farr & Gallagher LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
State University of New York at Old Westbury
 State University of New York at Old Westbury Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The United States Army (District of Columbia)
The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Government |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
The University of Iowa College of Law
 The University of Iowa College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
